Trial Profile
Randomised Phase II study of biweekly versus fractionated triweekly combination Taxotere-Cisplatin-5FU in advanced gastric and gastro-esophageal junction cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 15 Jan 2017 This trial was completed in Belgium, according to European Clinical Trials Database.
- 26 Sep 2014 New trial record